SPDR S&P Pharmaceuticals ETF
XPH
XPH
64 hedge funds and large institutions have $98.6M invested in SPDR S&P Pharmaceuticals ETF in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less capital invested
Capital invested by funds: $117M → $98.6M (-$18M)
84% less call options, than puts
Call options by funds: $250K | Put options by funds: $1.54M
Holders
64
Holding in Top 10
–
Calls
$250K
Puts
$1.54M
Top Buyers
| 1 | +$2.92M | |
| 2 | +$1.53M | |
| 3 | +$1.03M | |
| 4 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$696K |
| 5 |
IC
IEQ Capital
Foster City,
California
|
+$550K |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$2.6M | |
| 3 | -$2.05M | |
| 4 |
Jane Street
New York
|
-$887K |
| 5 |
CI
CX Institutional
Auburn,
Indiana
|
-$824K |